BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 11715018)

  • 41. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.
    Katayama H; Sasai K; Kawai H; Yuan ZM; Bondaruk J; Suzuki F; Fujii S; Arlinghaus RB; Czerniak BA; Sen S
    Nat Genet; 2004 Jan; 36(1):55-62. PubMed ID: 14702041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
    Arriola EL; Lopez AR; Chresta CM
    Oncogene; 1999 Jan; 18(4):1081-91. PubMed ID: 10023685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export.
    Shinozaki T; Nota A; Taya Y; Okamoto K
    Oncogene; 2003 Dec; 22(55):8870-80. PubMed ID: 14654783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2.
    Clark PA; Llanos S; Peters G
    Oncogene; 2002 Jul; 21(29):4498-507. PubMed ID: 12085228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.
    Buschmann T; Fuchs SY; Lee CG; Pan ZQ; Ronai Z
    Cell; 2000 Jun; 101(7):753-62. PubMed ID: 10892746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2.
    Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
    Breast Cancer Res; 2004; 6(5):R571-85. PubMed ID: 15318938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53 phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase, p14ARF, and p300/CBP during the cell cycle and after exposure to ultraviolet irradiation.
    Buschmann T; Adler V; Matusevich E; Fuchs SY; Ronai Z
    Cancer Res; 2000 Feb; 60(4):896-900. PubMed ID: 10706102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
    Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE
    Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
    Eischen CM; Alt JR; Wang P
    Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modification of MDMX by sumoylation.
    Pan Y; Chen J
    Biochem Biophys Res Commun; 2005 Jul; 332(3):702-9. PubMed ID: 15907800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.
    Mayo LD; Donner DB
    Trends Biochem Sci; 2002 Sep; 27(9):462-7. PubMed ID: 12217521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.
    Li L; Liao J; Ruland J; Mak TW; Cohen SN
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1619-24. PubMed ID: 11172000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function.
    Thomas A; White E
    Genes Dev; 1998 Jul; 12(13):1975-85. PubMed ID: 9649502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.
    Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J
    Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
    Zhu Q; Wani G; Wani MA; Wani AA
    Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.
    Rogoff HA; Pickering MT; Debatis ME; Jones S; Kowalik TF
    Mol Cell Biol; 2002 Aug; 22(15):5308-18. PubMed ID: 12101227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.
    Goldberg Z; Vogt Sionov R; Berger M; Zwang Y; Perets R; Van Etten RA; Oren M; Taya Y; Haupt Y
    EMBO J; 2002 Jul; 21(14):3715-27. PubMed ID: 12110584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism.
    Santos CR; Vega FM; Blanco S; Barcia R; Lazo PA
    Virology; 2004 Oct; 328(2):254-65. PubMed ID: 15464845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MDM2 does not influence p53-mediated sensitivity to DNA-damaging drugs.
    McKenzie PP; McPake CR; Ashford AA; Vanin EF; Harris LC
    Mol Cancer Ther; 2002 Oct; 1(12):1097-104. PubMed ID: 12481433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.
    Stommel JM; Wahl GM
    EMBO J; 2004 Apr; 23(7):1547-56. PubMed ID: 15029243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.